+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccine Vials Market by Type, Material, Capacity, Neck Finish - Global Forecast to 2030- Product Image
Vaccine Vials Market by Type, Material, Capacity, Neck Finish - Global Forecast to 2030- Product Image
Sale

Vaccine Vials Market by Type, Material, Capacity, Neck Finish - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146104
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As the healthcare landscape transforms, the vaccine vials market continues to evolve in response to rising immunization demand, supply chain adjustments, and advancing manufacturing technologies. This comprehensive analysis equips senior leaders with actionable intelligence to guide strategic investment and operational decisions within the primary packaging sector.

Market Snapshot: Vaccine Vials Market Size and Growth

The vaccine vials market grew from USD 697.72 million in 2024 to USD 775.79 million in 2025. It is projected to maintain a compound annual growth rate (CAGR) of 10.88%, reaching USD 1.29 billion by 2030. This expansion reflects continued public health initiatives, technological advancement, and shifts in global supply networks.

Scope & Segmentation: Vaccine Vial Dynamics Across the Value Chain

  • Container Types: Multi dose and single dose formats supporting varied immunization strategies.
  • Material Types: Range encompasses plastic (including cyclo olefin polymer and polyethylene terephthalate) and glass (Type I, II, III) options.
  • Container Sizes: Options include 2 mL, 5 mL, 10 mL, and 20 mL for applications from pediatrics to mass campaigns.
  • Neck Finishes: Choices such as crimp and screw impact product compatibility, integrity, and fill-finish efficiency.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, UAE, South Africa, France), and Asia-Pacific (e.g., China, India, Japan, Australia, South Korea).
  • Companies Profiled: Representative leaders include SCHOTT AG, Gerresheimer AG, Corning Incorporated, Stevanato Group S.p.A., SGD Pharma S.A., and others.
  • Key Technologies: Advanced materials (such as cyclo olefin polymers), modular manufacturing lines, in-line quality control, and digital traceability systems.

Key Takeaways: Strategic Insights Shaping the Vaccine Vials Market

  • Adaptable manufacturing, driven by modular plant architectures and flexible fill-finish platforms, is elevating operational efficiency for vial producers.
  • Collaboration between contract development organizations, biotech firms, and primary packaging specialists is redefining supply chain integration and reducing risk of production delays.
  • Regulatory streamlining is accelerating time-to-market for next-generation container closure systems designed for sensitive biologics and emerging therapies.
  • Materials innovation, especially in cyclo olefin polymer vials, is improving chemical resistance and supports the packaging of novel vaccine formulations.
  • Regional policy incentives in Asia-Pacific are propelling investment in facility upgrades and technology transfers, enhancing its position as a critical export hub.
  • Strategic diversification of supplier networks is mitigating the impact of global trade disruptions and supporting cost competitiveness.

Tariff Impact: U.S. Policy Adjustments and Global Supply Chains

U.S. tariff revisions in 2025 have increased duties on glass and polymer resins, prompting manufacturers to revisit sourcing models and enter joint ventures with North American suppliers. These adjustments have caused cost shifts, but firms employing nearshoring and renegotiated long-term contracts are offsetting impacts. Logistics providers are optimizing warehousing and transport to support new trade flows, demonstrating the importance of adaptive networks and procurement strategies in preserving margins.

Methodology & Data Sources

This report leverages primary interviews with executives and operational leaders across the vaccine vials market, complemented by secondary research from industry journals, regulatory filings, and consortium reports. Data triangulation with public disclosures and trade records ensures a balanced, validated perspective. Expert panels review findings throughout, and strict data governance safeguards information integrity and confidentiality.

Why This Report Matters

  • Provides granular benchmarking of competitive and regulatory dynamics for informed capex or partnership decisions.
  • Equips decision-makers with clear segmentation insights to optimize product portfolios and target growth-ready markets.
  • Identifies emerging risks and opportunity levers across global supply chains, empowering leaders to future-proof operations.

Conclusion

Rigorous analysis of market trends, segmentation, and supply chain factors empowers senior stakeholders to make data-driven decisions. The report delivers actionable insights for sustaining growth and ensuring resilient vaccine vial supply in the evolving healthcare environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vaccine Vials Market, by Type
8.1. Introduction
8.2. Multi Dose
8.3. Single Dose
9. Vaccine Vials Market, by Material
9.1. Introduction
9.2. Plastic
9.2.1. Cyclo Olefin Polymer
9.2.2. Polyethylene Terephthalate
9.3. Type I Glass
9.4. Type II Glass
9.5. Type III Glass
10. Vaccine Vials Market, by Capacity
10.1. Introduction
10.2. 10 Ml
10.3. 2 Ml
10.4. 20 Ml
10.5. 5 Ml
11. Vaccine Vials Market, by Neck Finish
11.1. Introduction
11.2. Crimp
11.3. Screw
12. Americas Vaccine Vials Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Vaccine Vials Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Vaccine Vials Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. SCHOTT AG
15.3.2. Gerresheimer AG
15.3.3. Corning Incorporated
15.3.4. Stevanato Group S.p.A.
15.3.5. SGD Pharma S.A.
15.3.6. Nipro Corporation
15.3.7. Bormioli Pharma S.p.A.
15.3.8. Ardagh Group S.A.
15.3.9. Shandong Pharmaceutical Glass Co., Ltd.
15.3.10. Vitro, S.A.B. de C.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VACCINE VIALS MARKET MULTI-CURRENCY
FIGURE 2. VACCINE VIALS MARKET MULTI-LANGUAGE
FIGURE 3. VACCINE VIALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY CYCLO OLEFIN POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE I GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE II GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE III GLASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY 10 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY 2 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY 20 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY 5 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VACCINE VIALS MARKET SIZE, BY CRIMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY SCREW, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 39. CANADA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 40. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 41. CANADA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 42. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 44. MEXICO VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 45. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 46. MEXICO VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 68. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 70. GERMANY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 71. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 72. GERMANY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 73. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 75. FRANCE VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 76. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 77. FRANCE VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 83. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 85. ITALY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 86. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 87. ITALY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 88. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 90. SPAIN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 91. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 92. SPAIN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 108. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. DENMARK VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 111. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 118. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 120. QATAR VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 121. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 122. QATAR VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 123. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 125. FINLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 126. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 127. FINLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 138. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 140. EGYPT VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 141. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 142. EGYPT VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 143. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. TURKEY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 146. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 147. TURKEY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 153. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 155. NORWAY VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 156. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 157. NORWAY VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 158. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 160. POLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 161. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 162. POLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 176. CHINA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 177. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 178. CHINA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 179. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 181. INDIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 182. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 183. INDIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 184. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 186. JAPAN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 187. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 188. JAPAN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 204. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 206. THAILAND VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 207. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 208. THAILAND VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN VACCINE VIALS MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN VACCINE VIALS MARKET SIZE, BY NECK FINISH, 2018-2030 (USD MILLION)
TABLE 234. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vaccine Vials market report include:
  • SCHOTT AG
  • Gerresheimer AG
  • Corning Incorporated
  • Stevanato Group S.p.A.
  • SGD Pharma S.A.
  • Nipro Corporation
  • Bormioli Pharma S.p.A.
  • Ardagh Group S.A.
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Vitro, S.A.B. de C.V.

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 775.79 Million
Forecasted Market Value ( USD ) by 2030 $ 1290 Million
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Depyrogenated Sterile Empty Vials Market by Product Type, Application, End User, Capacity, Sterilization Method - Global Forecast to 2030 - Product Image

Depyrogenated Sterile Empty Vials Market by Product Type, Application, End User, Capacity, Sterilization Method - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Vaccine Vials Market 2025-2033 - Product Image

Vaccine Vials Market 2025-2033

  • Report
  • 142 Pages
  • Global
From
Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 154 Pages
  • Global
From
Cryogenic Vials Market by Material, End User, Application, Volume, Sterility, Closure, Automation Compatibility - Global Forecast to 2030 - Product Image

Cryogenic Vials Market by Material, End User, Application, Volume, Sterility, Closure, Automation Compatibility - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Ampoules and Vials Market - Forecasts from 2025 to 2030 - Product Image

Ampoules and Vials Market - Forecasts from 2025 to 2030

  • Report
  • 122 Pages
  • Global
From

About the Vaccine Vials Market

In the medical devices industry, the vaccine vials market comprises a segment dedicated to manufacturing the small glass or plastic containers used to hold and preserve vaccine doses. Vaccine vials are a critical component in the packaging and distribution of vaccines, ensuring the sterility, stability, and delivery of the immunizing agents they contain. Various types of vials exist, ranging from single-dose to multi-dose formats, with differing levels of protection against light and temperature changes. The market for vaccine vials is driven by the necessities of vaccine storage and safety, scalability for mass immunization efforts, and innovations in material sciences that contribute to the preservation of the vaccine's efficacy. The landscape of companies within the vaccine vials market includes names like Schott AG, Gerresheimer AG, and Nipro Corporation. These firms specialize in the production of pharmaceutical packaging, including glass and polymer vials. Becton, Dickinson and Company (BD) is another key player, known for its range of medical supplies and devices, including vaccine vials. Corning Incorporated has also made contributions to the market with their Valor Glass packaging solutions specifically designed for the storage and protection of vaccines. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.